Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis

NCT00424398 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Conjunctivitis, Allergic

Interventions

DRUG: Bepreve
DRUG: Placebo
DRUG: Bepotastine Besilate

Sponsor

Bausch & Lomb Incorporated